Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2020
Reporting Period: This filing reports on events occurring on January 13, 2020, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated January 2020) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The company is providing forward-looking information via an attached investor presentation (Exhibit 99.1) for use in analyst meetings.
Legal Status: The information in this Item 7.01 and the referenced exhibit is furnished pursuant to Regulation FD and is not deemed "filed" under the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated January 2020) for specific financial guidance and operational outlook, as this 8-K only references the document.
- Verify the trading symbol "KIDS" on The NASDAQ Stock Market LLC.
- Confirm the company's status as an emerging growth company and its election regarding accounting standard transition periods.
- Note that the content of the investor presentation is not legally "filed" for liability purposes under Section 18 of the Exchange Act.